Cargando…

Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics

Fungal infections represent a serious global health problem, causing damage to health and the economy on the scale of millions. Although vaccines are the most effective therapeutic approach used to combat infectious agents, at the moment, no fungal vaccine has been approved for use in humans. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Inácio, Moisés Morais, Moreira, André Luís Elias, Cruz-Leite, Vanessa Rafaela Milhomem, Mattos, Karine, Silva, Lana O’Hara Souza, Venturini, James, Ruiz, Orville Hernandez, Ribeiro-Dias, Fátima, Weber, Simone Schneider, Soares, Célia Maria de Almeida, Borges, Clayton Luiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301004/
https://www.ncbi.nlm.nih.gov/pubmed/37367569
http://dx.doi.org/10.3390/jof9060633
_version_ 1785064709926420480
author Inácio, Moisés Morais
Moreira, André Luís Elias
Cruz-Leite, Vanessa Rafaela Milhomem
Mattos, Karine
Silva, Lana O’Hara Souza
Venturini, James
Ruiz, Orville Hernandez
Ribeiro-Dias, Fátima
Weber, Simone Schneider
Soares, Célia Maria de Almeida
Borges, Clayton Luiz
author_facet Inácio, Moisés Morais
Moreira, André Luís Elias
Cruz-Leite, Vanessa Rafaela Milhomem
Mattos, Karine
Silva, Lana O’Hara Souza
Venturini, James
Ruiz, Orville Hernandez
Ribeiro-Dias, Fátima
Weber, Simone Schneider
Soares, Célia Maria de Almeida
Borges, Clayton Luiz
author_sort Inácio, Moisés Morais
collection PubMed
description Fungal infections represent a serious global health problem, causing damage to health and the economy on the scale of millions. Although vaccines are the most effective therapeutic approach used to combat infectious agents, at the moment, no fungal vaccine has been approved for use in humans. However, the scientific community has been working hard to overcome this challenge. In this sense, we aim to describe here an update on the development of fungal vaccines and the progress of methodological and experimental immunotherapies against fungal infections. In addition, advances in immunoinformatic tools are described as an important aid by which to overcome the difficulty of achieving success in fungal vaccine development. In silico approaches are great options for the most important and difficult questions regarding the attainment of an efficient fungal vaccine. Here, we suggest how bioinformatic tools could contribute, considering the main challenges, to an effective fungal vaccine.
format Online
Article
Text
id pubmed-10301004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103010042023-06-29 Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics Inácio, Moisés Morais Moreira, André Luís Elias Cruz-Leite, Vanessa Rafaela Milhomem Mattos, Karine Silva, Lana O’Hara Souza Venturini, James Ruiz, Orville Hernandez Ribeiro-Dias, Fátima Weber, Simone Schneider Soares, Célia Maria de Almeida Borges, Clayton Luiz J Fungi (Basel) Review Fungal infections represent a serious global health problem, causing damage to health and the economy on the scale of millions. Although vaccines are the most effective therapeutic approach used to combat infectious agents, at the moment, no fungal vaccine has been approved for use in humans. However, the scientific community has been working hard to overcome this challenge. In this sense, we aim to describe here an update on the development of fungal vaccines and the progress of methodological and experimental immunotherapies against fungal infections. In addition, advances in immunoinformatic tools are described as an important aid by which to overcome the difficulty of achieving success in fungal vaccine development. In silico approaches are great options for the most important and difficult questions regarding the attainment of an efficient fungal vaccine. Here, we suggest how bioinformatic tools could contribute, considering the main challenges, to an effective fungal vaccine. MDPI 2023-05-31 /pmc/articles/PMC10301004/ /pubmed/37367569 http://dx.doi.org/10.3390/jof9060633 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Inácio, Moisés Morais
Moreira, André Luís Elias
Cruz-Leite, Vanessa Rafaela Milhomem
Mattos, Karine
Silva, Lana O’Hara Souza
Venturini, James
Ruiz, Orville Hernandez
Ribeiro-Dias, Fátima
Weber, Simone Schneider
Soares, Célia Maria de Almeida
Borges, Clayton Luiz
Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
title Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
title_full Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
title_fullStr Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
title_full_unstemmed Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
title_short Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
title_sort fungal vaccine development: state of the art and perspectives using immunoinformatics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301004/
https://www.ncbi.nlm.nih.gov/pubmed/37367569
http://dx.doi.org/10.3390/jof9060633
work_keys_str_mv AT inaciomoisesmorais fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT moreiraandreluiselias fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT cruzleitevanessarafaelamilhomem fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT mattoskarine fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT silvalanaoharasouza fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT venturinijames fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT ruizorvillehernandez fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT ribeirodiasfatima fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT webersimoneschneider fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT soaresceliamariadealmeida fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics
AT borgesclaytonluiz fungalvaccinedevelopmentstateoftheartandperspectivesusingimmunoinformatics